BG108339A - Лечение на деменция и дегенеративни разстройства с междинни дози lhrh-антагонисти - Google Patents
Лечение на деменция и дегенеративни разстройства с междинни дози lhrh-антагонисти Download PDFInfo
- Publication number
- BG108339A BG108339A BG108339A BG10833903A BG108339A BG 108339 A BG108339 A BG 108339A BG 108339 A BG108339 A BG 108339A BG 10833903 A BG10833903 A BG 10833903A BG 108339 A BG108339 A BG 108339A
- Authority
- BG
- Bulgaria
- Prior art keywords
- use according
- methyl
- lhrh antagonist
- monthly
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28743401P | 2001-04-30 | 2001-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
BG108339A true BG108339A (bg) | 2004-11-30 |
Family
ID=23102886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG108339A BG108339A (bg) | 2001-04-30 | 2003-11-10 | Лечение на деменция и дегенеративни разстройства с междинни дози lhrh-антагонисти |
Country Status (28)
Country | Link |
---|---|
US (1) | US7288517B2 (fr) |
EP (1) | EP1392348B1 (fr) |
JP (1) | JP2004529207A (fr) |
KR (1) | KR20040000446A (fr) |
CN (1) | CN1317030C (fr) |
AT (1) | ATE400287T1 (fr) |
AU (1) | AU2002310788B2 (fr) |
BG (1) | BG108339A (fr) |
BR (1) | BR0209290A (fr) |
CA (1) | CA2444876A1 (fr) |
CZ (1) | CZ20033167A3 (fr) |
DE (1) | DE60227507D1 (fr) |
DK (1) | DK1392348T3 (fr) |
ES (1) | ES2307760T3 (fr) |
HK (1) | HK1072000A1 (fr) |
HU (1) | HUP0400067A2 (fr) |
IL (1) | IL156777A0 (fr) |
MX (1) | MXPA03008666A (fr) |
NO (1) | NO20034322D0 (fr) |
NZ (1) | NZ544417A (fr) |
PL (1) | PL362319A1 (fr) |
PT (1) | PT1392348E (fr) |
RU (1) | RU2319501C2 (fr) |
SI (1) | SI1392348T1 (fr) |
SK (1) | SK14512003A3 (fr) |
UA (1) | UA80679C2 (fr) |
WO (1) | WO2002102401A1 (fr) |
ZA (1) | ZA200305326B (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
US20020077327A1 (en) * | 1999-09-23 | 2002-06-20 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
ES2261437T3 (es) | 2000-07-05 | 2006-11-16 | Astellas Pharma Inc. | Derivados de propano-1,3-diona. |
DE10137174A1 (de) * | 2001-07-31 | 2003-02-13 | Zentaris Ag | Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität |
WO2005118556A1 (fr) * | 2004-06-04 | 2005-12-15 | Astellas Pharma Inc. | Dérivé de propane-1,de 3-dione ou son sel |
US20080171736A1 (en) * | 2004-12-23 | 2008-07-17 | Gregory Christopher W | Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists |
WO2006071274A2 (fr) * | 2004-12-23 | 2006-07-06 | Voyager Pharmaceutical Corporation | Acetate de leuprolide et inhibiteurs de l'acetylcholinesterase ou antagonistes des recepteurs nmda pour le traitement de la maladie d'alzheimer |
CA2603185C (fr) | 2005-03-31 | 2011-07-26 | Astellas Pharma Inc. | Derive de propane-1,3-dione ou sel de celui-ci |
JP5406030B2 (ja) * | 2006-10-21 | 2014-02-05 | アボット ゲーエムベーハー ウント カンパニー カーゲー | 複素環化合物およびそれらのグリコーゲンシンターゼキナーゼ3阻害薬としての使用 |
US20100190722A1 (en) * | 2007-09-11 | 2010-07-29 | Dorian Bevec | Substance p and thyrotropin releasing hormone for therapeutic applications |
AU2008297899A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of human neuropeptide as a therapeutic agent |
EP2095818A1 (fr) * | 2008-02-29 | 2009-09-02 | AEterna Zentaris GmbH | Utilisation d'antagonistes LHRH dans des doses n'impliquant pas de castration |
US20110129532A1 (en) * | 2008-05-29 | 2011-06-02 | Isr Immune System Regulation Ab | Method and means for treating viral disease, in particular hiv/aids |
MX336726B (es) | 2010-09-27 | 2016-01-27 | Abbott Gmbh & Co Kg | Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintasa quinasa-3. |
US9090592B2 (en) | 2010-12-30 | 2015-07-28 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
EP3560555A1 (fr) * | 2018-04-26 | 2019-10-30 | LifeArc | Composition pour traiter une ou plusieurs maladies liées aux strogènes |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3135743A (en) | 1960-06-29 | 1964-06-02 | Sterling Drug Inc | Steroido[2. 3-d]isoxazoles and preparation thereof |
JP2000511532A (ja) * | 1996-05-20 | 2000-09-05 | メルク エンド カンパニー インコーポレーテッド | 性腺刺激ホルモン放出ホルモンのアンタゴニスト |
DE19911771B4 (de) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung |
NZ515460A (en) * | 1999-05-14 | 2004-06-25 | Neurocrine Biosciences Inc | Imidazo- and pyrrolo[1,2-A]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists |
CA2309395A1 (fr) * | 1999-06-04 | 2000-12-04 | Richard Lloyd Bowen | Methodes de prevention et de traitement de la maladie d'alzheimer |
DE60022769T2 (de) | 1999-10-15 | 2006-07-06 | Neurocrine Biosciences, Inc., San Diego | Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen |
CA2406832A1 (fr) | 2000-04-13 | 2002-10-10 | Takeda Chemical Industries, Ltd. | Agents preventifs/remedes pour la maladie d'alzheimer |
ES2261437T3 (es) * | 2000-07-05 | 2006-11-16 | Astellas Pharma Inc. | Derivados de propano-1,3-diona. |
-
2002
- 2002-04-27 PT PT02735312T patent/PT1392348E/pt unknown
- 2002-04-27 CA CA002444876A patent/CA2444876A1/fr not_active Abandoned
- 2002-04-27 AU AU2002310788A patent/AU2002310788B2/en not_active Ceased
- 2002-04-27 CN CNB028042964A patent/CN1317030C/zh not_active Expired - Fee Related
- 2002-04-27 EP EP02735312A patent/EP1392348B1/fr not_active Expired - Lifetime
- 2002-04-27 PL PL36231902A patent/PL362319A1/xx not_active Application Discontinuation
- 2002-04-27 MX MXPA03008666A patent/MXPA03008666A/es active IP Right Grant
- 2002-04-27 IL IL15677702A patent/IL156777A0/xx unknown
- 2002-04-27 ES ES02735312T patent/ES2307760T3/es not_active Expired - Lifetime
- 2002-04-27 HU HU0400067A patent/HUP0400067A2/hu unknown
- 2002-04-27 KR KR10-2003-7014128A patent/KR20040000446A/ko not_active Application Discontinuation
- 2002-04-27 UA UA2003109180A patent/UA80679C2/uk unknown
- 2002-04-27 BR BR0209290-5A patent/BR0209290A/pt not_active IP Right Cessation
- 2002-04-27 DE DE60227507T patent/DE60227507D1/de not_active Expired - Fee Related
- 2002-04-27 AT AT02735312T patent/ATE400287T1/de not_active IP Right Cessation
- 2002-04-27 JP JP2003504987A patent/JP2004529207A/ja not_active Withdrawn
- 2002-04-27 SK SK1451-2003A patent/SK14512003A3/sk unknown
- 2002-04-27 WO PCT/EP2002/004677 patent/WO2002102401A1/fr active IP Right Grant
- 2002-04-27 NZ NZ544417A patent/NZ544417A/en unknown
- 2002-04-27 US US10/133,967 patent/US7288517B2/en not_active Expired - Fee Related
- 2002-04-27 DK DK02735312T patent/DK1392348T3/da active
- 2002-04-27 SI SI200230730T patent/SI1392348T1/sl unknown
- 2002-04-27 RU RU2003134949/14A patent/RU2319501C2/ru not_active IP Right Cessation
- 2002-04-27 CZ CZ20033167A patent/CZ20033167A3/cs unknown
-
2003
- 2003-07-10 ZA ZA200305326A patent/ZA200305326B/xx unknown
- 2003-09-26 NO NO20034322A patent/NO20034322D0/no not_active Application Discontinuation
- 2003-11-10 BG BG108339A patent/BG108339A/bg unknown
-
2005
- 2005-06-08 HK HK05104803A patent/HK1072000A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60227507D1 (de) | 2008-08-21 |
KR20040000446A (ko) | 2004-01-03 |
HK1072000A1 (en) | 2005-08-12 |
CZ20033167A3 (cs) | 2004-08-18 |
RU2003134949A (ru) | 2005-02-10 |
EP1392348A1 (fr) | 2004-03-03 |
UA80679C2 (en) | 2007-10-25 |
JP2004529207A (ja) | 2004-09-24 |
ATE400287T1 (de) | 2008-07-15 |
NO20034322L (no) | 2003-09-26 |
MXPA03008666A (es) | 2004-10-15 |
NO20034322D0 (no) | 2003-09-26 |
HUP0400067A2 (hu) | 2004-04-28 |
NZ544417A (en) | 2008-03-28 |
DK1392348T3 (da) | 2008-09-29 |
ZA200305326B (en) | 2003-07-30 |
AU2002310788B2 (en) | 2007-04-05 |
SK14512003A3 (sk) | 2004-08-03 |
EP1392348B1 (fr) | 2008-07-09 |
CN1575185A (zh) | 2005-02-02 |
CA2444876A1 (fr) | 2002-12-27 |
SI1392348T1 (sl) | 2008-12-31 |
US20020177556A1 (en) | 2002-11-28 |
ES2307760T3 (es) | 2008-12-01 |
BR0209290A (pt) | 2004-07-13 |
RU2319501C2 (ru) | 2008-03-20 |
CN1317030C (zh) | 2007-05-23 |
US7288517B2 (en) | 2007-10-30 |
WO2002102401A1 (fr) | 2002-12-27 |
PL362319A1 (en) | 2004-10-18 |
PT1392348E (pt) | 2008-09-09 |
IL156777A0 (en) | 2004-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG108339A (bg) | Лечение на деменция и дегенеративни разстройства с междинни дози lhrh-антагонисти | |
EP1663236B1 (fr) | Combinaison a base de n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulfonamide et d'un bisphosphonate | |
JP2020040971A (ja) | 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト | |
AU2002310788A1 (en) | Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists | |
JP2006502969A (ja) | 内因性性腺刺激ホルモン産生の増強 | |
US20090054319A1 (en) | Methods and Compositions for the Treatment of Hypertension and Gastrointestinal Disorders | |
DE60314896T2 (de) | 5-ht 1b/1d rezeptor agonisten zur behandlung von kopfschmerz der aus der verabreichung von endothelin rezeptor antagonisten resultiert | |
DE69927705T2 (de) | Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen-gonadenachse | |
US11872219B2 (en) | Compositions and methods for intrathecal administration of MCOPPB for pain relief | |
CN1501802A (zh) | 芳基乙烯磺酰胺衍生物的新用途 | |
EP1610771B1 (fr) | Utilisation d'un antagoniste de l'adrenorecepteur alpha-2 pour le traitement de l'epilepsie | |
US20040157772A1 (en) | Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis | |
EP0998923A1 (fr) | Utilisation des agonistes du recepteur 5-HT7 pour le traitement ou la prophylaxe des ischémies | |
AU2002305989A1 (en) | The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis | |
FR2919803A1 (fr) | Utilisation d'un antagoniste non peptidique du recepteur b1 pour la preparation de medicaments utiles pour le traitement de l'obesite et des pathologies liees a l'obesite ou au diabete |